cryptocurrency bit Related searches

The dollar rose to 152.91 yen against the yen, the highest since November 27.Pfizer announced an increase in its quarterly dividend, and American pharmaceutical giant Pfizer said on Thursday that it would increase its quarterly dividend by 2.4%, from 42 cents to 43 cents per share. The new dividend is equivalent to $1.72 per year, which means that the annual yield is about 6.8%. Albert Bourla, CEO of Pfizer, said that the dividend increase highlighted the company's strong financial performance, execution and commitment to return capital to shareholders.Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.

Intel executives said that whether to split the company is still an open question. Dave Zinsner, chief financial officer of Intel, said that whether to formally split the factory and product development department is an open question and will be decided by the next leader. After Pat Gelsinger was forced to leave his post earlier this month, Zinsner is now the interim co-CEO. He made the comments when attending the Barclays Technology Conference in San Francisco on Thursday. Michelle Johnston Holthaus, another co-CEO, was also present.Futures on the Nikkei Stock Exchange of Singapore opened down 175 points to 39,635.The leading enterprises in the quantum science and technology sector are competing for layout. Recently, the quantum science and technology sector has been active. Since September 24, the concept index of the straight flush quantum science and technology has risen by more than 60%, and the stock prices of many stocks have doubled. Among A-share listed companies, many companies including China Mobile, China Telecom, Guo Dun Quantum, Hexin Instrument, Guoxin Technology and Geer Software have already laid out in the field of quantum technology. In terms of future market potential, ICVTA&K, a scientific and technological consulting organization, predicts that in 2023, the overall market size of the global quantum industry may reach 7.24 billion US dollars. However, the current quantum technology industry is still in the stage of research and development and industrial exploration. Taking quantum computing as an example, Guo Dun Quantum said in a survey conducted by an organization on November 15th that quantum computers have only achieved quantum superiority in some specific problems at present, and it is estimated that it will take about 5 to 10 years to surpass classical computing power in practical and valuable problems in the future. (Economic Information Daily)

Bank of Japan: The confidence index of large manufacturers rose to the highest level since March 2022.Onlikon: The cooperative product Aidit calcitonin soft capsules is planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13th, and on December 12th, the company received a notice from its partner Beijing Meifurun Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Meifurun") that the Aidit calcitonin soft capsules jointly developed by the company and its wholly-owned subsidiary Wenzhou Haihe Pharmaceutical Co., Ltd. are planned to be selected for the tenth batch of national centralized drug procurement. According to the Pharmaceutical Cooperation Agreement signed by the company and its partner Mei Furun, the company owns 50% of the cooperative products.Meta released a new AI tool, which can enhance the experience of the Meta-universe. On Thursday, the American technology giant Meta said that it would release an artificial intelligence model called Meta Motivo, which can control the actions of a digital agent similar to human beings and may enhance the experience of the meta-universe. According to the company, Meta Motivo solves the common body control problems in digital avatars, enabling them to exercise in a more realistic and human-like way. "We believe that this research can pave the way for a fully concrete agent in the meta-universe, resulting in a more realistic NPC (non-player character), democratization of character animation, and a new immersive experience."